Michal Gutman (from right) CTO & CISO, Maayan Cohen, Co-Founder and CEO, and Ziv Meltzer, Co-Founder, Chief Design. Photo Hello Heart
Hello Heart, an Israeli medtech startup offering a digital program that helps users to understand and improve their heart health, has raised $70 million in Series D financing. The news comes one year after Hello Heart raised $45 million in a Series C round of funding led by IVP. The company has now raised $138 million to date.
Israeli firms are at the forefront of new medical technologies and Israeli researchers seem to come up with new medical treatments on almost a daily basis. So Hello Heart is not alone and if Israel’s track record in the field continues it should do quite well. For example, just last month Viz.ai, an Israeli medtech startup that offers AI-powered disease detection and care coordination platform, hit the coveted unicorn status with a $1.2 billion valuation when the company raised $100 million in a Series D funding round.
Founded in 2013, Hello Heart boasts that it is the only digital therapeutics company to focus exclusively on heart disease, which is the number one cause of death for men and women in the US. Through a connected mobile app that uses AI, behavioral science, and personalized digital coaching to drive lifestyle changes, Hello Heart helps people to embrace healthier behavior, which can reduce the risks of high blood pressure and heart disease. It also helps users catch readings that are extremely high, encourage them to talk to their doctor and catch potential risk in time.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
So, how does the Hello Heart tech work? Well, every participant receives a wireless blood pressure monitor and real-time personalized tips on their smartphone. The solution, says the company, helps participants improve their heart health in a fun and engaging way. Hello Heart delivers real results – enrollment rates are 45% of targeted employees, and 70% of participants at risk reduce their blood pressure using Hello Heart.
“Hypertension affects 47% of Americans, and heart health in some way touches all of us. Everyone has a family member or colleague that is affected by heart disease. We empower people to understand, manage, and self-improve their heart health using the app technology and behavioral science,” said Maayan Cohen, Co-Founder and CEO of Hello Heart. “We make it easy for employers to work with Hello Heart, and it just works. We are thrilled to be working with so many of the nation’s leading employers as they empower their employees to make smart and healthy choices.”
